Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | FBP1 | P09467 | 2/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29434852 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP2C19MEN1KMT2ACA2 | |
| SCHEMBL7370658 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP2C19MEN1KMT2ACA2 | |
| SCHEMBL7348679 | 0.78 | MEN1 (0.64) | CYP1A2CYP2C19MEN1KMT2ACA2 | |
| SCHEMBL7372796 | 0.77 | CYP1A2 (0.62) | CYP1A2CYP2C19MEN1KMT2ACYP2D6 | |
| SCHEMBL13038637 | 0.74 | MEN1 (0.59) | CYP1A2CYP2C19MEN1KMT2AKEAP1 | |
| SCHEMBL2451043 | 0.73 | CYP1A2 (0.57) | CYP1A2CYP2C19MEN1KMT2ACYP2D6 | |
| SCHEMBL1410564 | 0.73 | KEAP1 (0.61) | CYP1A2CYP2C19MEN1KMT2ACYP2D6 | |
| SCHEMBL12648709 | 0.73 | CYP1A2 (0.61) | CYP1A2CYP2C19MEN1KMT2ACA2 | |
| SCHEMBL1411424 | 0.73 | KEAP1 (0.61) | CYP1A2CYP2C19MEN1KMT2ACYP2D6 | |
| SCHEMBL2451041 | 0.73 | CYP1A2 (0.57) | CYP1A2CYP2C19MEN1KMT2ACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12543959-B2 | Device, system and method for monitoring of peripheral arterial perfusion of a subject | KONINKLIJKE PHILIPS N.V. (NL) | 2026-02-10 | — | — | US | disclosed |
| US-20250221824-A1 | METHOD AND SYSTEM FOR FABRICATING OBJECT FEATURING PROPERTIES OF A HARD TISSUE | STRATASYS LTD. (IL) | 2025-07-10 | — | — | US | disclosed |
| CN-119770006-A | Wearable multi-mode hemodynamic monitoring device and method | 重庆大学 | 2025-04-08 | — | — | CN | disclosed |
| US-20250111889-A1 | DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES | UNIVERSITY OF WASHINGTON | 2025-04-03 | — | — | US | disclosed |
| EP-3496604-B1 | DEVICE AND SYSTEM FOR MONITORING OF PERIPHERAL ARTERIAL PERFUSION OF A SUBJECT | KONINKLIJKE PHILIPS NV (NL) | 2025-02-12 | — | — | EP | disclosed |
| US-12223910-B2 | Display panel | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-02-11 | — | — | US | disclosed |
| CN-119097289-A | Signal acquisition method, device, storage medium, electronic device, and program product | 中国科学院大学 | 2024-12-10 | — | — | CN | disclosed |
| CN-116189264-B | Heart rate recognition method based on facial feature point recognition and signal empirical mode decomposition | 杭州微帮忙智慧科技有限公司 | 2024-12-03 | — | — | CN | disclosed |
| CN-112566906-B | Substituted quinazolinone derivatives and their use as positive allosteric modulators of MGLUR4 | 多曼治疗学公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-115956890-B | Remote light volume method blood pressure real-time identification method based on signal variation modal decomposition | 杭州微帮忙智慧科技有限公司 | 2024-09-03 | — | — | CN | disclosed |
| CN-115956890-A | Remote light volume method blood pressure real-time identification method based on signal variation modal decomposition | 中促(杭州)信息科技有限公司 | 2023-04-14 | — | — | CN | disclosed |
| CN-109561843-B | Apparatus, system and method for monitoring peripheral arterial perfusion of a subject | 皇家飞利浦有限公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-108471989-B | Device, system and method for generating a photoplethysmographic image carrying vital sign information of a subject | 皇家飞利浦有限公司 | 2022-04-26 | — | — | CN | disclosed |
| US-20220089609-A1 | SUBSTITUTED QUINAZOLINONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR4 | DOMAIN THERAPEUTICS (FR) | 2022-03-24 | — | — | US | disclosed |
| US-9034798-B2 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | CAPROTEC BIOANALYTICS GMBH (DE) | 2015-05-19 | — | — | US | disclosed |
| US-8569481-B2 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | PHARMACEUTICALS, INC. (US) | 2013-10-29 | — | — | US | disclosed |
| US-20110118136-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | KOESTER HUBERT | 2011-05-19 | — | — | US | disclosed |
| US-20100298168-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | HK PHARMACEUTICALS, INC. | 2010-11-25 | — | — | US | disclosed |
| US-20100248264-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | HK PHARMACEUTICALS, INC. | 2010-09-30 | — | — | US | disclosed |
| WO-1997021715-A1 | ALPHA-CYCLOPROPYL-SUBSTITUTED PHENYLGLYCINES AS CNS AGENTS | UNIVERSITY OF BRISTOL (GB) | 1997-06-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118136-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | PTMS, QPCTL, SRMS | CYP1A2 4732/4885CYP2C19 4485/4885MEN1 3426/4885 |
| US-20250111889-A1 | DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES | DHFR, CCNH, ODC1 | CYP1A2 3673/4885CYP2C19 4311/4885MEN1 2382/4885 |
| US-12543959-B2 | Device, system and method for monitoring of peripheral arterial perfusion of a subject | LIPG, PFKP, PDE6G | CYP1A2 2237/4885CYP2C19 1356/4885MEN1 3755/4885 |
| US-20100298168-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | CHLSN, PTMS, SRMS | CYP1A2 4648/4885CYP2C19 4619/4885MEN1 2224/4885 |
| US-20220089609-A1 | SUBSTITUTED QUINAZOLINONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR4 | GRIK4, GRM4, GRIA4 | CYP1A2 3562/4885CYP2C19 2590/4885MEN1 4634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.